" class="no-js "lang="en-US"> Sartorius Stedim Biotech - Medtech Alert
Monday, August 11, 2025
Sartorius Stedim Biotech | Pharmtech Focus

Sartorius Stedim Biotech

About Sartorius Stedim Biotech

Sartorius Stedim Biotech

Many diseases, such as cancer, dementia or inflammatory diseases, are still incurable. Hundreds of millions of people lack access to affordable and safe medicines. Our biopharma customers are working hard to develop new drugs to improve people’s lives.

The Sartorius Group is a leading international partner of life science research and the biopharmaceutical industry, listed on the German MDAX and TecDAX stock markets. In fiscal 2020, the company recorded sales of €2.34 billion, growing by around 30%.

Our ambition is to simplify progress in biopharmaceutical research and production. We support our customers with innovative technologies that make the development and manufacture of innovative therapeutics faster and more efficient. So that more people have access to better medicine. Nearly 11,000 employees at over 60 production and sales locations worldwide are committed to this vision.

As one of the fasted-growing global life science companies, we are looking for people who share our ambition and want to make a contribution in a vibrant environment while growing their careers.

Related Story

Sartorius BIA Separations and Exopharm Sign Joint Research Agreement to Develop Integrated Technology for Large-scale Exosome Production

November 24 2022

Sartorius BIA Separations, a leading bio-chromatography company, now part of the international life science group […]

BioNet and Sartorius’ Company BIA Separations Collaborate on Production Process Development of mRNA Vaccines

November 2 2021

BioNet, a leading biotech company manufacturing genetically engineered vaccines, and BIA Separations, now part of […]

McMaster, Sartorius Stedim Biotech Team up to Advance Biomanufacturing Processes with Next-Gen Tech

August 25 2021

Sartorius Stedim Biotech, a leading international partner of the biopharmaceutical industry, has entered into a […]